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Abstract
The heterogeneity of symptoms associated with autism spectrum disorders (ASDs) has presented a significant challenge to
genetic analyses. Even when associations with genetic variants have been identified, it has been difficult to associate them
with a specific trait or characteristic of autism. Here, we report that quantitative trait analyses of ASD symptoms combined
with case-control association analyses using distinct ASD subphenotypes identified on the basis of symptomatic profiles
result in the identification of highly significant associations with 18 novel single nucleotide polymorphisms (SNPs). The
symptom categories included deficits in language usage, non-verbal communication, social development, and play skills, as
well as insistence on sameness or ritualistic behaviors. Ten of the trait-associated SNPs, or quantitative trait loci (QTL), were
associated with more than one subtype, providing partial replication of the identified QTL. Notably, none of the novel SNPs
is located within an exonic region, suggesting that these hereditary components of ASDs are more likely related to gene
regulatory processes (or gene expression) than to structural or functional changes in gene products. Seven of the QTL reside
within intergenic chromosomal regions associated with rare copy number variants that have been previously reported in
autistic samples. Pathway analyses of the genes associated with the QTL identified in this study implicate neurological
functions and disorders associated with autism pathophysiology. This study underscores the advantage of incorporating
both quantitative traits as well as subphenotypes into large-scale genome-wide analyses of complex disorders.
Citation: Hu VW, Addington A, Hyman A (2011) Novel Autism Subtype-Dependent Genetic Variants Are Revealed by Quantitative Trait and Subphenotype
Association Analyses of Published GWAS Data. PLoS ONE 6(4): e19067. doi:10.1371/journal.pone.0019067
Editor: Fatah Kashanchi, George Mason University, United States of America
Received February 2, 2011; Accepted March 18, 2011; Published April 27, 2011
Copyright:  2011 Hu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: There was no direct funding for this study other than Dr. Hu’s salary. Therefore, there were no funders who had a role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bcmvwh@gwumc.edu
Introduction
Autism spectrum disorders (ASDs) represent a group of
neurodevelopmental disorders that are characterized by impaired
reciprocal social interactions, delayed or aberrant communication,
and stereotyped, repetitive behaviors, often with restricted interests
[1,2]. With a concordance rate as high as 90% based on twin
studies [3], ASDs are among the most heritable of neuropsychi-
atric conditions. Although specific genes have been found to be
causal for several syndromes that are sometimes associated with
autistic symptoms (for example, Fragile X [4], Retts [5,6], and
tuberous sclerosis [7,8], there are no unequivocal genetic markers
for non-syndromic idiopathic autism. Thus, a considerable
amount of effort has been devoted to identifying genetic mutations
or variants that associate with these perplexing and often
devastating, life-long disorders. Because of the relatively high
prevalence of ASDs in the general population (,1:110), genome-
wide association (GWA) analyses have been used recently to search
for common variants that may associate with increased suscepti-
bility to this set of disorders [9–12]. However, despite case-control
studies that have now exceeded many thousands of subjects and
more than 500,000 SNPs, only a few significantly associated SNPs
have been identified. In addition, replication of these SNPs in
independent studies has not been successful. The inability to
replicate findings from GWA analyses may be in part due to the
genetic heterogeneity of the ASD population, thus giving rise to
increased ‘‘noise’’ in the data. This genetic heterogeneity is likely
responsible for the well-noted phenotypic and symptomatic
heterogeneity among individuals with autism.
In a recent paper, we demonstrated that the ASD population
can be divided into at least 4 phenotypic subgroups on the basis of
cluster analyses of 123 severity scores taken from each individual’s
diagnostic assessment using the Autism Diagnostic Interview-
Revised [13]. The resulting subgroups included one with severe
language impairment, another with mild severity across all items, a
third of intermediate severity, and a fourth of moderate severity
with a higher frequency of savant skills. We further demonstrated
by gene expression profiling of lymphoblastoid cell lines from 3 of
these subgroups (excluding the intermediate) and nonautistic
controls that cells from each of these subgroups exhibited
differentially expressed genes relative to those of the controls,
but also were distinguishable from each other in terms of unique,
subtype-specific differentially expressed genes [14]. These studies
thus support the concept that different subgroups of autistic
individuals may exhibit subtype-dependent biological differences
due to genetic variation. We therefore hypothesized that genetic
association analyses of such ASD subtypes with SNPs that are
identified and filtered according to their association with
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SNPs with increased statistical power. Here, we report the
identification of 18 novel and highly significant SNPs that are
associated with at least one of 4 different subtypes of ASDs, based
on the combination of quantitative trait association analyses and
subtype-dependent genetic association analyses using trait-associ-
ated SNPs, with 10 of these SNPs replicated in a second ASD
subtype representing an independent case cohort.
Results
The overarching goal of these studies was to identify single
nucleotide polymorphisms (SNPs) that are associated with both
autistic traits and clinical subtypes of autism that are manifested by
separate case cohorts. To accomplish this, we combined
quantitative trait analysis and subphenotype association analyses
using the wealth of genome-wide association (GWA) data
published by Wang et al. in 2009 [9].
Quantitative Trait Association Analyses
The flowchart in Fig. 1 describes the experimental design and
analyses that were used to derive the combined set of 18 novel and
statistically significant SNPs that associate with 4 separate subtypes
of ASDs. Raw item scores from the ADI-R score sheets of 2939
ASD cases were summed for spoken language skills, non-verbal
communication, play skills, social development, and insistence on
sameness/rituals, as described previously [13]. The specific items
used to obtain the total score per ‘‘trait’’ category for each
individual are shown in Table S1 and the profiles of total scores
for each category are shown for the 2939 individuals in Fig. S1.
We then conducted quantitative trait association analyses using the
distribution of scores in each of the categories to identify sets of
SNPs that associate with symptomatic severity of each of the
behaviors listed in Table S1. A nominal p-value#10
25 was used in
this ‘‘discovery phase’’ designed to screen candidate SNPs that are
potentially of functional significance with respect to the ASD traits.
These sets of symptom-associated SNPs (or quantitative trait loci,
QTL) are shown in Table S2.
ASD subtype-dependent genetic association analyses
with trait-associated SNPs
Next, we performed cluster analyses as described by Hu and
Steinberg [13] to divide the autistic cases into 4 non-overlapping
phenotypic subgroups according to symptomatic severity profiles
derived from 123 items on the ADI-R assessments. We postulated
that this subtyping procedure, which reduces the behavioral/
symptomatic heterogeneity among the cases within each subgroup,
is likely to also restrict the genetic heterogeneity within each
subgroup. The results of K-means cluster analyses (K=4) of the
ADIR data from the 2939 individuals (which included 1867
genotyped cases from the GWA study) is shown in Fig. S2A.A n
unsupervised principal components analysis (PCA) was used to
demonstrate that the 4 subgroups of individuals with ASDs from
the K-means cluster analyses results in effective separation of cases
according to similarity of symptomatic profile as defined by the
123 item scores from the ADI-R (Fig. S2B). The resulting
phenotypic subgroups were then used in genetic association
analyses with each set of QTL derived from the five quantitative
trait association analyses, where the cases were either divided into
Figure 1. Diagram of study design illustrating sequential application of quantitative trait and subphenotype association analyses.
The quantitative trait association analyses were performed with 1867 cases for which the ADI-R assessments were available, using the complete set of
genetic polymorphisms to identify SNPs that may have functional relevance to traits associated with ASDs. This had the net effect of filtering the set
of SNPs from 513,312 to 167 QTL. In the second phase, each set of trait-associated SNPs (QTL) were employed in case-control association analyses
with 2438 controls and the combined cases (1867) as well as with 4 ASD subgroups, each representing an independent cohort of cases (363–639
cases per subtype). From these analyses, only 18 QTL with Bonferroni-adjusted p-values,0.05 in at least one subtype for each trait were combined
for the final set of genetic association analyses using combined cases as well as ASD subtypes against the controls.
doi:10.1371/journal.pone.0019067.g001
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2438 nonautistic controls. These analyses produced 5 sets of QTL
that were associated with specific subtypes of ASDs (Tables 1, 2,
3, 4, 5). It is interesting to note that SNPs associated with certain
genes (such as HTR4, BACH2, and TINAG among Language
QTL, and OR5B3, OR5B17, and ERBB4 among Nonverbal
QTL) are replicated in more than one ASD subtype. Finally,
significant SNPs with Bonferroni-adjusted p-values#0.05 from
each of the 4 separate subtype-dependent association analyses with
QTL were combined into a single set containing 18 unique SNPs,
and case-control association analyses were performed for which
the cases were either combined into one group or divided
according to subphenotype.
Partial replication of SNPs between subtypes of ASDs
Table 6 shows the SNPs associated with each subtype of ASDs
that resulted from the final association analyses using the
combined highly significant QTL and 4 non-overlapping
subgroups of ASD cases. Eighteen of the SNPs have p-
values,0.05 in at least one subtype even after using the stringent
Bonferroni correction for multiple comparisons. Note that 10 of
the SNPs, including rs317985, rs7785107, rs11671930,
rs7950390, rs12266938, rs3861787, rs7725785, rs1827924,
rs1231339, and rs757099, are associated with more than one
subtype. Two of the replicated SNPs (rs317985 and rs7785107)
are significant in two subtypes after Bonferroni adjustment
(p,0.05), while the remaining 8 exhibit lower levels of signi-
ficance (nominal p-values from 0.0037–0.051 or FDR_BH
adjusted p-values of 0.0087–0.088) in the second (or third)
subtype. Association of these QTL with more than one subtype of
ASD serves as a replication for these 10 SNPs. While the
replication of SNPs in different subtypes may be interpreted as
evidence for those SNPs being highly penetrant for ASDs, the
subtype-dependent differences in minor allele frequency (MAF)
and odds ratios (OR) associated with the shared SNPs suggest
that the subtypes are genetically heterogeneous. Figure 2
summarizes the extent of SNP overlap among the 4 ASD
subtypes (case cohorts) and clearly demonstrates that the odds
ratios are distinctly different for different subtypes that share the
same SNP. All of the QTL associated with specific genes are
present in non-exonic (promoter, intronic, or intergenic) regions.
Interestingly, all but one of the SNPs residing within intergenic
regions can be associated by band position to rare copy number
variants (CNV) that have been recently identified for ASDs [15],
thus providing further support for the probable relevance of these
SNPs to ASDs. These CNVs are noted in Table 6.
Table 1. Language QTL associated with ASD subtypes.
SNP SNP position Band Location Gene UNADJ P FDR_BH
a BONF
b Subtype
rs2277049 chr5:147883281 5q33.1 Intron HTR4 0.0002 0.0015 0.0036 Language-impaired
rs757099 chr9:25727567 9p21.2 CNV* 0.0003 0.0015 0.0055 "
rs7785107 chr7:10247968 7p21.3 CNV 0.0003 0.0015 0.0059 "
rs7725785 chr5:147882896 5q33.1 Intron (boundary) HTR4 0.0004 0.0015 0.0062 "
rs2287581 chr5:31341022 5p13.3 Intron (boundary) CDH6 0.0007 0.0019 0.0111 "
rs1231339 chr9:25730863 9p21.2 CNV 0.0007 0.0019 0.0116 "
rs2180055 chr22:47722427 22q13.32 CNV 0.0015 0.0036 0.0252 "
rs758158 chr12:1895465 12p13.33 Intron CACNA2D4 0.0032 0.0067 0.0538 "
rs17830215 chr8:1902159 8p23.3 Promoter KBTBD11 0.0043 0.0082 0.0739 "
rs10183984 chr2:167181162 2q24.3 CNV 0.0060 0.0101 0.1013 "
rs11969265 chr6:90739765 6q15 Intron BACH2 0.0080 0.0124 0.1359 "
rs9474831 chr6:54361040 6p12.1 Intron TINAG 0.0099 0.0141 0.1688 "
rs17828521 chr6:54328202 6p12.1 Intron TINAG 0.0116 0.0145 0.1977 "
rs10806416 chr6:90755541 6q15 Intron BACH2 0.0120 0.0145 0.2036 "
rs6454792 chr6:90743794 6q15 Intron BACH2 0.0349 0.0395 0.5927 "
rs12893752 chr14:25220350 14q12 CNV 0.0918 0.0975 1.0000 "
rs7785107 chr7:10247968 7p21.3 CNV 0.0016 0.0265 0.0265 Intermediate
rs12407665 chr1:14070302 1p36.21 CNV 0.0005 0.0093 0.0093 Mild
rs12893752 chr14:25220350 14q12 CNV 0.0068 0.0576 0.1151 "
rs6454792 chr6:90743794 6q15 Intron BACH2 0.0137 0.0747 0.2330 "
rs1231339 chr9:25730863 9p21.2 CNV 0.0215 0.0747 0.3662 "
rs9474831 chr6:54361040 6p12.1 Intron TINAG 0.0220 0.0747 0.3736 "
rs10183984 chr2:167181162 2q24.3 CNV 0.0356 0.0928 0.6059 "
rs17828521 chr6:54328202 6p12.1 Intron TINAG 0.0382 0.0928 0.6495 "
rs757099 chr9:25727567 9p21.2 CNV 0.0441 0.0938 0.7503 "
rs7725785 chr5:147882896 5q33.1 Intron (boundary) HTR4 0.0508 0.0960 0.8639 "
ap-value adjusted using Benjamini-Hochberg False Discovery Rate method;
bBonferroni-adjusted p-value.
*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t001
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identified SNPs within Chr5p14.1
Because none of the SNPs identified in this re-analysis
overlapped with those of the previously published genome-wide
association study [9], we examined the association of the 6 SNPs
that were reported in the published study with our subphenotypes.
Table 7 shows that only the ‘‘Moderate’’ ASD subtype (363 cases)
is associated with two of the SNPs, with Bonferroni-adjusted p-
values of 0.035 and 0.053. Interestingly, these 2 SNPs have the
least significant combined p-values in the published study. The
remaining 4 SNPs were suggestively significant with FDR_BH-
Table 2. Nonverbal communication QTL associated with ASD subtypes.
SNP SNP Position Band Location Gene UNADJ FDR_BH
a BONF
b Subtype
rs1231339 chr9:25730863 9p21.2 CNV* 0.0007 0.0177 0.0177 Language-impaired
rs519514 chr7:78294084 7q21.11 Intron MAGI2 0.0031 0.0397 0.0793 "
rs11138895 chr9:82693023 9q21.31 - 0.0046 0.0401 0.1203 "
rs564127 chr7:79734155 7q21.11 CNV 0.0065 0.0423 0.1690 "
rs12466917 chr2:207427129 2q33.3 - 0.0159 0.0828 0.4141 "
rs11229411 chr11:57926918 11q12.1 Coding exon OR5B3 0.0096 0.0898 0.2488 Intermediate
rs11229413 chr11:57927314 11q12.1 Coding exon OR5B3 0.0102 0.0898 0.2646 "
rs12279895 chr11:57926572 11q12.1 Coding exon OR5B3 0.0108 0.0898 0.2806 "
rs11229410 chr11:57926867 11q12.1 Coding exon OR5B3 0.0138 0.0898 0.3590 "
rs1938670 chr11:57884219 11q12.1 Promoter OR5B17 0.0176 0.0916 0.4579 "
rs1938651 chr11:57869527 11q12.1 CNV 0.0046 0.0511 0.1190 Moderate
rs1938672 chr11:57885629 11q12.1 Promoter OR5B17 0.0060 0.0511 0.1560 "
rs11229410 chr11:57926867 11q12.1 Coding exon OR5B3 0.0084 0.0511 0.2186 "
rs1938670 chr11:57884219 11q12.1 Promoter OR5B17 0.0094 0.0511 0.2441 "
rs11229413 chr11:57927314 11q12.1 Coding exon OR5B3 0.0112 0.0511 0.2919 "
rs11229411 chr11:57926918 11q12.1 Coding exon OR5B3 0.0123 0.0511 0.3190 "
rs12279895 chr11:57926572 11q12.1 Coding exon OR5B3 0.0138 0.0511 0.3580 "
rs9941626 chr2:212059912 2q34 Intron ERBB4 0.0170 0.0554 0.4431 "
rs13021324 chr2:212058490 2q34 Intron ERBB4 0.0288 0.0831 0.7483 "
rs7930778 chr11:57792932 11q12.1 Promoter OR10W1 0.0341 0.0887 0.8866 "
rs730168 chr16:73707776 16q23.1 Intron LDHD 0.0002 0.0036 0.0040 Mild
rs11671930 chr19:8023308 19p13.2 Promoter CCL25 0.0003 0.0036 0.0073 "
rs13205238 chr6:413597 6p25.3 CNV 0.0033 0.0287 0.0860 "
rs12962411 chr18:27645521 18q12.1 CNV 0.0107 0.0522 0.2784 "
rs393076 chr3:162584791 3q26.1 CNV 0.0143 0.0522 0.3715 "
rs11229411 chr11:57926918 11q12.1 Coding exon OR5B3 0.0146 0.0522 0.3794 "
rs11229413 chr11:57927314 11q12.1 Coding exon OR5B3 0.0156 0.0522 0.4050 "
rs11229410 chr11:57926867 11q12.1 Coding exon OR5B3 0.0191 0.0522 0.4961 "
rs4804202 chr19:12579619 19p13.2 Promoter FLJ90396 0.0203 0.0522 0.5282 "
rs1231339 chr9:25730863 9p21.2 CNV 0.0215 0.0522 0.5600 "
rs1938670 chr11:57884219 11q12.1 Promoter OR5B17 0.0221 0.0522 0.5737 "
rs12279895 chr11:57926572 11q12.1 Coding exon OR5B3 0.0252 0.0530 0.6554 "
rs11138895 chr9:82693023 9q21.31 - 0.0265 0.0530 0.6887 "
rs1938651 chr11:57869527 11q12.1 CNV 0.0288 0.0535 0.7490 "
rs9941626 chr2:212059912 2q34 Intron ERBB4 0.0337 0.0555 0.8772 "
rs1938672 chr11:57885629 11q12.1 Promoter OR5B17 0.0342 0.0555 0.8886 "
rs4527692 chr6:21268426 6p22.3 Intron CDKAL1 0.0376 0.0574 0.9764 "
rs665036 chr1:61053139 1p31.3 CNV 0.0412 0.0595 1.0000 "
rs7930778 chr11:57792932 11q12.1 Promoter OR10W1 0.0464 0.0634 1.0000 "
rs13021324 chr2:212058490 2q34 Intron ERBB4 0.0569 0.0706 1.0000 "
rs3133855 chr11:120090061 11q23.3 Intron GRIK4 0.0570 0.0706 1.0000 "
ap-value adjusted using Benjamini-Hochberg False Discovery Rate method;
bBonferroni-adjusted p-value.
*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t002
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(1867 individuals in all) as well as the other 3 ASD subtypes
show no association with any of the 6 SNPs even though there
a r em o r ec a s e si ne a c ho ft h e s eg r o u p st h a ni nt h eM o d e r a t e
group. This finding further illustrates the value of analyzing
subphenotypes of ASDs in genome-wide association analyses in
order to reduce the genetic heterogeneity of the population
studied.
Pathway analyses of SNP-containing genes
To obtain a better understanding of how the novel SNPs
identified in this study potentially relate to the biology of autism,
Table 3. Play skills QTL associated with ASD subtypes.
SNP SNP Position Band Location Gene UNADJ P FDR_BH
a BONF
b Subtype
rs3754741 chr2:173761465 2q31.1 Intron ZAK 0.0016 0.0641 0.1025 Language-
impaired
rs9569991 chr13:33121745 13q13.2 - 0.0025 0.0641 0.1614 "
rs4798405 chr18:5732206 18p11.31 CNV* 0.0030 0.0641 0.1923 "
rs8181738 chr12:23095146 12p12.1 - 0.0045 0.0726 0.2906 "
rs1554547 chr12:97892279 12q23.1 Intron ANKS1B 0.0068 0.0865 0.4324 "
rs1481513 chr8:79171163 8q21.12 CNV 0.0084 0.0893 0.5356 "
rs730168 chr16:73707776 16q23.1 Intron LDHD 0.0002 0.0060 0.0098 Mild
rs6482516 chr10:18879356 10p12.33 Intron NSUN6 0.0002 0.0060 0.0123 "
rs11671930 chr19:8023308 19p13.2 Promoter CCL25 0.0003 0.0060 0.0179 "
rs11082277 chr18:38304361 18q12.3 CNV 0.0016 0.0221 0.1053 "
rs6698676 chr1:84528583 1p31.1 Promoter SAMD13 0.0017 0.0221 0.1105 "
rs1461710 chr18:38197191 18q12.3 CNV 0.0029 0.0265 0.1877 "
rs3745651 chr19:12553001 19p13.2 Coding exon ZNF490 0.0030 0.0265 0.1920 "
rs13205238 chr6:413597 6p25.3 CNV 0.0033 0.0265 0.2117 "
rs4386512 chr3:177012791 3q26.31 Downstream NAALADL2 0.0048 0.0310 0.3067 "
rs6791089 chr3:176998117 3q26.31 Intron NAALADL2 0.0052 0.0310 0.3342 "
rs9536962 chr13:54576937 13q21.1 CNV 0.0057 0.0310 0.3638 "
rs2250595 chr12:45642394 12q13.11 - 0.0058 0.0310 0.3716 "
rs4894734 chr3:177013204 3q26.31 Downstream NAALADL2 0.0075 0.0342 0.4794 "
rs1481513 chr8:79171163 8q21.12 CNV 0.0079 0.0342 0.5064 "
rs7337921 chr13:23381053 13q12.12 Intron FLJ46358 0.0080 0.0342 0.5124 "
rs1863080 chr2:36379940 2p22.3 CNV 0.0094 0.0365 0.5996 "
rs7944323 chr11:78903676 11q14.1 CNV 0.0097 0.0365 0.6206 "
rs10987251 chr9:128142815 9q33.3 Intron (boundary) C9orf28 0.0151 0.0508 0.9679 "
rs6974649 chr7:130463637 7q32.3 CNV 0.0156 0.0508 1.0000 "
rs4894733 chr3:177013074 3q26.31 Downstream NAALADL2 0.0166 0.0508 1.0000 "
rs9508456 chr13:28914362 13q12.3 Intron KIAA0774 0.0172 0.0508 1.0000 "
rs1796045 chr2:96986737 2q11.2 CNV 0.0175 0.0508 1.0000 "
rs11229410 chr11:57926867 11q12.1 Coding exon OR5B3 0.0191 0.0529 1.0000 "
rs4745257 chr9:75582705 9q21.13 CNV 0.0202 0.0529 1.0000 "
rs12606567 chr18:48408860 18q21.2 Intron DCC 0.0211 0.0529 1.0000 "
rs2044747 chr14:42393956 14q21.2 CNV 0.0215 0.0529 1.0000 "
rs4646421 chr15:72803245 15q24.1 Intron CYP1A1 0.0251 0.0595 1.0000 "
rs1440423 chr5:34425616 5p13.2 CNV 0.0269 0.0600 1.0000 "
rs1888156 chr9:128142661 9q33.3 Coding exon C9orf28 0.0272 0.0600 1.0000 "
rs9941626 chr2:212059912 2q34 Intron ERBB4 0.0337 0.0720 1.0000 "
rs2078520 chr2:80246156 2p12 Intron CTNNA2 0.0376 0.0776 1.0000 "
rs1796028 chr2:96982680 2q11.2 CNV 0.0417 0.0834 1.0000 "
rs1482930 chr15:79651018 15q25.2 CNV 0.0488 0.0946 1.0000 "
rs11627027 chr14:93440170 14q32.13 - 0.0529 0.0995 1.0000 "
ap-value adjusted using Benjamini-Hochberg False Discovery Rate method;
bBonferroni-adjusted p-value.
*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t003
Novel SNPs Associated with Autism Subtypes
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19067pathway analysis was conducted to develop a better sense of the
relationships among the SNP-associated genes and their impact on
higher level functions and diseases. Fig. 3 shows a gene network
constructed using Pathway Studio 7 which includes seven of the 9
genes associated with SNPs found within gene promoters or
introns. Of the 7 genes, HTR4 and GCH1 are ‘‘hubs’’ showing
the highest ‘‘connectivity’’ with other components within the
network. The specific relationships between these two genes and
other network components are more clearly illustrated in Figures
S3 and S4. It is noted that many of the cellular and higher level
processes in this network, such as neurogenesis, axonogenesis,
steroid metabolism, cell proliferation, long-term synaptic potenti-
ation, learning and memory are relevant to identified deficits in
ASDs.
Discussion
We have previously shown that the autistic population can be
divided into subgroups of affected individuals according to
symptomatic profile through cluster analyses of severity scores
from the ADI-R assessment for each individual with an ASD [13].
Three of the 4 resulting subgroups were shown to exhibit distinct,
though partially overlapping, gene expression profiles, each
relative to a group of nonautistic controls, implying that both
unique and shared genes are associated with the respective
phenotypes [14]. We therefore applied the same rationale and
methods in subtyping individuals with ASDs for this re-analysis of
previously published genome-wide association data [9]. We first
employed quantitative trait association analyses to the .500,000
SNPs tested in order to prioritize SNPs that might correlate with a
behavioral or symptomatic ‘‘trait’’ relevant to ASDs. These
quantitative traits for each individual with an ASD were derived
from the sums of severity scores from the ADI-R items that
described severity of language impairment, deficits in nonverbal
communication, impaired play skills, insistence on sameness/
rituals, and delayed social development. The specific items used to
establish each quantitative trait (listed in Table S1) were shown by
Hu and Steinberg to exhibit differential severity among the several
subtypes of ASDs [13]. In this ‘‘discovery’’ stage of the experiment,
quantitative trait association analyses across the 5 selected traits
produced a filtered set of 167 unique SNPs from the original
513,312 SNPs (Table S2). Subsequent association analyses of
these QTL with both combined and subtyped individuals with
ASDs revealed 18 novel SNPs which were found to be highly
significant (Bonferroni-adjusted p-value,0.05) in at least one
subtype of autism (Table 6). Interestingly, many of the language
QTL from Table S2 are strongly associated with the severely
language-impaired ASD subtype. Of the 18 novel SNPs, 10 SNPs
were replicated, albeit at a more modest significance level, in at
least one of the other subtypes. Two are replicated with
Bonferroni-significant p-values while the other 8 are suggestively
significant (FDR-BH adjusted p-value,0.09). While it may be
argued that the standard statistical methods used here to correct
for multiple testing are not stringent enough, there is still no clear
consensus on the significance level that is appropriate for a
candidate gene (or SNP) study such as this, where the candidate
SNPs are determined by prior quantitative trait association
analyses. More significantly, different minor allele frequencies
and odds ratios are observed for the SNPs that are associated with
more than one subtype (Table 6 and Fig. 2), thus reflecting the
genetic heterogeneity among the ASD phenotypes, which is teased
apart by the subtyping procedures employed here. It is noteworthy
that no significant SNPs were identified when all 1867 individuals
with ASDs were analyzed against 2438 nonautistic controls, thus
underscoring the importance of phenotypic subtyping to unearth-
ing SNP associations with ASDs.
By comparison, the original genome-wide study which was
based on the combined analysis of 2503 cases and more than 7000
Table 4. Insistence on sameness QTL associated with ASD subtypes.
SNP SNP Position Band Location Gene UNADJ FDR_BH
a BONF
b Subtype
rs1827924 chr2:228377979 2q36.3 Promoter CCL20 0.0002 0.0053 0.0053 Moderate
rs17738966 chr14:54371969 14q22.2 Downstream GCH1 0.0005 0.0071 0.0171 "
rs7950390 chr11:4587928 11p15.4 Promoter TRIM68 0.0007 0.0071 0.0212 "
rs3861787 chr11:4604346 11p15.4 CNV* 0.0012 0.0078 0.0385 "
rs317985 chr5:66773558 5q13.1 CNV 0.0012 0.0078 0.0392 "
rs3804967 chr3:7479914 3p26.1 Intron GRM7 0.0022 0.0119 0.0712 "
rs3804968 chr3:7477700 3p26.1 Intron GRM7 0.0033 0.0131 0.1069 "
rs13096022 chr3:7465129 3p26.1 Intron GRM7 0.0034 0.0131 0.1102 "
rs6782718 chr3:7462776 3p26.1 Intron GRM7 0.0037 0.0131 0.1182 "
rs9568011 chr13:47606812 13q14.2 - 0.0047 0.0152 0.1518 "
rs164187 chr1:160615261 1q23.3 Promoter C1orf111 0.0070 0.0205 0.2251 "
rs10781238 chr9:76384432 9q21.13 Intron RORB 0.0101 0.0240 0.3221 "
rs9634811 chr13:47362176 13q14.2 - 0.0103 0.0240 0.3303 "
rs2469183 chr15:84992924 15q25.3 CNV 0.0105 0.0240 0.3363 "
rs317985 chr5:66773558 5q13.1 CNV 0.0023 0.0584 0.0727 Mild
rs1827924 chr2:228377979 2q36.3 Promoter CCL20 0.0037 0.0584 0.1168 "
rs2574852 chr17:73003467 17q25.3 Intron SEPT9 0.0057 0.0609 0.1826 "
ap-value adjusted using Benjamini-Hochberg False Discovery Rate method;
bBonferroni-adjusted p-value.
*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t004
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identified 1 SNP that reached genome-wide significance and 5
additional SNPs of nominal significance in one intergenic region
on chr5p14.1 that was located between 2 cadherin genes [9]. In
this study, we replicated the association of 2 of the SNPs but only
in the ‘‘Moderate’’ subtype of ASDs which consisted of only 363
cases (Table 7). Neither the other 3 subtypes (with 387–639 cases
per subgroup) nor the combined cases group (consisting of 1867
cases) showed any association with these 6 SNPs. Furthermore,
while none of the 6 SNPs identified in the published study
correlated with expression level of either cadherin (CDH9 or
CDH10) in the cortical brain of 93 genotyped human subjects, we
note that 2 of the SNP-associated genes identified in the current
study, HTR4 and CCL25, were found to be differentially
expressed (FDR,5%) in lymphoblastoid cell lines from individuals
with ASDs in a previous study by our laboratory [14]. This overlap
of differentially expressed genes with those associated with at least
some of the novel SNPs lends support to the potential functional
relevance of these SNPs. Aside from the SNPs located within the
promoter or intron regions of genes, seven of the other eight
significant SNPs (Table 6) are located in intergenic regions that are
linked by band position to rare copy number variants (CNVs) that
Table 5. Social development QTL associated with ASD subtypes.
SNP SNP Position Band Location Gene UNADJ P FDR_BH
a BONF
b Subtype
rs12266938 chr10:3852940 10p15.1 CNV* 0.0001 0.0023 0.0023 Mild
rs10519124 chr2:67819501 2p14 - 0.0002 0.0040 0.0081 "
rs2297172 chr9:71563166 9q21.11 Intron PTAR1 0.0006 0.0082 0.0245 "
rs2255313 chr12:102773924 12q23.3 CNV 0.0014 0.0150 0.0613 "
rs6698676 chr1:84528583 1p31.1 Promoter SAMD13 0.0017 0.0150 0.0760 "
rs2519866 chr17:27859883 17q11.2 Intron MYO1D 0.0020 0.0150 0.0900 "
rs10305860 chr4:148625337 4q31.23 Intron EDNRA 0.0028 0.0176 0.1229 "
rs13205238 chr6:413597 6p25.3 CNV 0.0033 0.0182 0.1456 "
rs4873815 chr8:144796206 8q24.3 Promoter ZNF623 0.0042 0.0182 0.1836 "
rs4832481 chr2:16986218 2p24.3 CNV 0.0045 0.0182 0.1959 "
rs30746 chr5:135366157 5q31.1 CNV 0.0046 0.0182 0.2006 "
rs10997162 chr10:67906707 10q21.3 Intron CTNNA3 0.0054 0.0196 0.2357 "
rs3809282 chr12:110192180 12q24.11 Intron CUTL2 0.0061 0.0205 0.2664 "
rs12115722 chr9:133418328 9q34.13 CNV 0.0069 0.0218 0.3049 "
rs10874468 chr2:96959718 2q11.2 CNV 0.0099 0.0277 0.4361 "
rs4809918 chr20:50734607 20q13.2 - 0.0106 0.0277 0.4642 "
rs12962411 chr18:27645521 18q12.1 CNV 0.0107 0.0277 0.4712 "
rs4959923 chr6:412773 6p25.3 CNV 0.0129 0.0316 0.5679 "
rs721087 chr2:4942340 2p25.2 CNV 0.0166 0.0385 0.7312 "
rs9479482 chr6:150399705 6q25.1 - 0.0180 0.0397 0.7937 "
rs10788819 chr1:150161717 1q21.3 - 0.0198 0.0414 0.8690 "
rs4646421 chr15:72803245 15q24.1 Intron CYP1A1 0.0251 0.0502 1.0000 "
rs11138895 chr9:82693023 9q21.31 CNV 0.0265 0.0507 1.0000 "
rs11138885 chr9:82678684 9q21.31 - 0.0300 0.0550 1.0000 "
rs4905110 chr14:93432083 14q32.13 - 0.0329 0.0570 1.0000 "
rs2627468 chr8:3812607 8p23.2 Intron CSMD1 0.0349 0.0570 1.0000 "
rs17192980 chr5:7030768 5p15.31 CNV 0.0350 0.0570 1.0000 "
rs10886048 chr10:118928872 10q25.3 CNV 0.0426 0.0660 1.0000 "
rs4811895 chr20:55639715 20q13.31 - 0.0435 0.0660 1.0000 "
rs13384439 chr2:187500106 2q32.1 CNV 0.0462 0.0678 1.0000 "
rs4416176 chr2:26536150 2p23.3 Intron OTOF 0.0507 0.0708 1.0000 "
rs11627027 chr14:93440170 14q32.13 - 0.0529 0.0708 1.0000 "
rs12183587 chr6:150396301 6q25.1 - 0.0531 0.0708 1.0000 "
rs2151206 chr9:14844072 9p22.3 Intron FREM1 0.0562 0.0727 1.0000 "
rs6022029 chr20:50708572 20q13.2 CNV 0.0606 0.0762 1.0000 "
rs1996893 chr9:14880268 9p22.3 Intron FREM1 0.0726 0.0887 1.0000 "
ap-value adjusted using Benjamini-Hochberg False Discovery Rate method;
bBonferroni-adjusted p-value.
*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t005
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all 18 of the novel SNPs are in non-exonic (promoter and
noncoding) regions further suggests that gene regulatory processes
likely leading to differential gene expression, rather than to
alterations of gene products, may contribute to the hereditary
component of ASDs. The presence of the identified QTL in ASD-
related CNVs provides additional support for the potential
relevance of these novel SNPs to ASDs. The current study thus
illustrates the advantage of combining both quantitative traits and
defined ASD phenotypes in analyzing genome-wide genetic data
from individuals with this complex disorder.
Quantitative trait and phenotype incorporation into
genetic analyses
There have been relatively few large-scale genetic studies on
ASDs that incorporate quantitative traits or phenotypes into
genome-wide analyses. The value of using phenotypic subsets of
ASDs in genetic analyses was demonstrated in an early linkage
Table 6. Highly significant SNPs associated with ASD subtypes.
CHR SNP BP A1
a F_A
b F_U
c A2
d CHISQ
e OR
f Band Location Gene UNADJ FDR_BH
g BONF
h
Subtype
(#cases)
5 rs2277049 147883281 A 0.115 0.081 C 13.71 1.48 5q33.1 Intron HTR4 0.0002 0.0017 0.0041 Language
(639)
9 rs757099 25727567 C 0.391 0.447 T 12.94 0.79 9p21.2 CNV* 0.0003 0.0017 0.0061 "
7 rs7785107 10247968 T 0.031 0.056 G 12.79 0.54 7p21.3 CNV 0.0003 0.0017 0.0066 "
5 rs7725785 147882896 A 0.114 0.082 C 12.71 1.44 5q33.1 Intron
(boundary)
HTR4 0.0004 0.0017 0.0069 "
5 rs2287581 31341022 A 0.078 0.053 G 11.62 1.51 5p13.3 Intron
(boundary)
CDH6 0.0007 0.0022 0.0124 "
9 rs1231339 25730863 A 0.534 0.480 C 11.54 1.24 9p21.2 CNV 0.0007 0.0022 0.0129 "
22 rs2180055 47722427 T 0.146 0.113 C 10.1 1.34 22q13.32 CNV 0.0015 0.0040 0.0281 "
19 rs11671930 8023308 C 0.135 0.160 T 4.809 0.82 19p13.2 Promoter CCL25 0.0283 0.0598 0.5379 "
7 rs7785107 10247968 T 0.083 0.056 G 10.01 1.52 7p21.3 CNV 0.0016 0.0296 0.0296 Intermed
(478)
11 rs7950390 4587928 G 0.107 0.080 T 7.51 1.38 11p15.4 Promoter TRIM68 0.0061 0.0370 0.1166 "
10 rs12266938 3852940 C 0.236 0.198 T 7.14 1.25 10p15.1 CNV 0.0075 0.0370 0.1432 "
11 rs3861787 4604346 T 0.102 0.076 G 7.081 1.38 11p15.4 CNV 0.0078 0.0370 0.1480 "
2 rs1827924 228377979 G 0.256 0.326 A 14.2 0.71 2q36.3 Promoter CCL20 0.0002 0.0031 0.0031 Moderate
(363)
14 rs17738966 54371969 A 0.131 0.090 G 11.99 1.52 14q22.2 Downstream GCH1 0.0005 0.0042 0.0102 "
11 rs7950390 4587928 G 0.044 0.080 T 11.59 0.53 11p15.4 Promoter TRIM68 0.0007 0.0042 0.0126 "
11 rs3861787 4604346 T 0.043 0.076 G 10.49 0.54 11p15.4 CNV 0.0012 0.0047 0.0229 "
5 rs317985 66773558 A 0.321 0.264 G 10.45 1.32 5q13.1 CNV 0.0012 0.0047 0.0233 "
5 rs7725785 147882896 A 0.058 0.082 C 5.168 0.69 5q33.1 Intron
(boundary)
HTR4 0.0230 0.0729 0.4372 "
10 rs12266938 3852940 C 0.137 0.198 T 16.33 0.64 10p15.1 CNV 0.0001 0.0009 0.0010 Mild (387)
16 rs730168 73707776 A 0.173 0.234 G 14.34 0.68 16q23.1 Intron LDHD 0.0002 0.0009 0.0029 "
2 rs10519124 67819501 A 0.187 0.137 G 13.99 1.46 2p14 0.0002 0.0009 0.0035 "
10 rs6482516 18879356 A 0.310 0.247 G 13.91 1.37 10p12.33 Intron NSUN6 0.0002 0.0009 0.0037 "
19 rs11671930 8023308 C 0.212 0.160 T 13.21 1.42 19p13.2 Promoter CCL25 0.0003 0.0011 0.0053 "
9 rs2297172 71563166 C 0.093 0.139 T 11.92 0.64 9q21.11 Intron PTAR1 0.0006 0.0018 0.0106 "
5 rs317985 66773558 A 0.212 0.264 G 9.317 0.75 5q13.1 CNV 0.0023 0.0062 0.0431 "
2 rs1827924 228377979 G 0.380 0.326 A 8.45 1.26 2q36.3 Promoter CCL20 0.0037 0.0087 0.0693 "
9 rs1231339 25730863 A 0.436 0.480 C 5.283 0.83 9p21.2 CNV 0.0215 0.0455 0.4092 "
9 rs757099 25727567 C 0.486 0.447 T 4.051 1.17 9p21.2 CNV 0.0441 0.0839 0.8386 "
5 rs7725785 147882896 A 0.062 0.082 C 3.814 0.74 5q33.1 Intron
(boundary)
HTR4 0.0508 0.0878 0.9655 "
aMinor allele;
bMinor allele frequency-autistic cases;
cMAF-unaffected controls;
dMajor allele;
eChiSquare value;
fOdds ratio with respect to major allele;
gp-value adjusted using Benjamini-Hochberg False Discovery Rate method;
hBonferroni-adjusted p-value.
*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t006
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families) according to presence or absence of savant skills increased
the HLOD score of the D15S511 marker within the GABRB3
gene on chr15q11–q13 from 0.8 in the entire study population to
2.6 for the savant-skills-positive subset of individuals [16]. Later,
Alarcon et al. used quantitative trait analysis of 2 language scores
on the ADI-R combined with ordered subsets analysis for subject
stratification to reveal a strong language QTL on 7q35, and
observed additional linkage peaks on several other chromosomes
without stratification [17]. Chen et al. used a combination of 7
ADI-R scores describing nonverbal communication and the same
approach to uncover QTL for nonverbal communication [18].
Similarly, Duvall et al. used quantitative trait analysis based upon
scores from the Social Responsiveness Scale to discover QTL for
social endophenotypes with strong linkage to chromosomes 11 and
17 across all samples and additional linkages to chromosomes 4, 8,
and 10 in ‘‘male-only’’ families [19]. More recently, Nijmeijer
et al. identified loci overlapping ASDs and attention-deficit/
hyperactivity disorder (ADHD) in a genome-wide study of children
with ADHD and autistic traits (but not classical or atypical autism)
by using total and subscale scores from the Social Communication
Questionnaire (an autism diagnostic instrument) as well as by
including scores related to severity of ADHD as covariates [20].
Along a similar vein, Ronald et al. examined both social and non-
social autistic-like traits in the general population, quantified on
the basis of DSM-IV social and non-social scales, to tease out 22
and 20 SNPs that associated with these traits, respectively [21].
However, only one SNP survived testing in an independent sample
and its p-value was still only nominally significant in an all male
sample. Recently, quantitative trait analysis was applied in a
genome-wide linkage study of two repetitive ASD behavior
phenotypes, ‘‘insistence on sameness’’ (IS) and ‘‘repetitive and
stereotyped behavior’’ (RSMA) [22]. In this study, Cannon et al.
demonstrated IS and RSMA were linked to 2 separate loci, each
exhibiting respective HLOD scores of 3.42 and 3.93, suggesting
that more narrowly-defined phenotypes improve linkage signals.
When social behavior, as reflected by severity scores on the Social
Responsiveness Scale was used as a quantitative trait, Coon et al.
not only replicated a susceptibility locus identified previously in the
Duvall et al. study [19], but also identified additional linkage peaks
with HLOD scores ranging from 2.23–3.64 [23]. Interestingly, St.
Pourcain et al. recently reported that one of the SNPs identified at
Chr5p14 by GWA analyses [9] also associates by quantitative trait
analyses with the social communication phenotype [24]. They
Figure 2. SNPs shared between subtypes exhibit different odds ratios. A) Venn diagram showing unique and shared SNPs across ASD
subtypes. B) Table listing the shared SNPs and odds ratios in different ASD subtypes. Shading indicates SNPs with p-values that are ,0.09 according
to FDR_BH correction methods for multiple testing, while the unshaded SNPs have Bonferroni-adjusted p-values,0.05. For both (A) and (B), the
subtypes are color-coded as follows: Red – Language-impaired; Green – Intermediate; Yellow – Moderate; Blue – Mild.
doi:10.1371/journal.pone.0019067.g002
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subthreshold impairments across a variety of ASD-related functions.
In the present study, we observe that rs4307059 is suggestively
associated only with the Moderate ASD subtype, with an
unadjusted p-value of 0.074 (Table 7). Thus, the above-mentioned
studies, in combination with ours, reinforce the concept that the
incorporation of quantitative traits into genetic analyses greatly
improves the ability to elicit significant genetic information on
complex disorders such as ASDs. Furthermore, the genes
associated with the QTL in Tables 1, 2, 3,4, 5 and Table S2
may provide clues to the biology underlying the various autistic
traits. Our study, which uniquely combines QTL with ASD subtype-
dependent genetic association analyses, provides an additional refinement
to genome-wide studies that results not only in the identification of
a greater number of significant SNPs, but also concomitant and
internal validation of SNPs that are replicated between and among
the ASD subtypes which represent independent cohorts of affected
individuals. Since the number of individuals in each subgroup
ranges from 363–639, our study also demonstrates the increased
statistical power inherent in this approach. Clearly, there are many
ways that individuals with ASDs can be divided into subgroups
(such as by regression following normal development, co-morbid
symptoms, IQ, etc.), and some of these methods may prove to be
superior to the method described here and in our previous study
[13]. However, the importance of using phenotypically distinct
cohorts in large-scale genetic association analyses is illustrated here
using a method that is capable of distinguishing meaningful
phenotypes across the whole spectrum of ASDs (severe to mild),
based on severity profiles across a broad range of behaviors and
symptoms characteristic of ASDs.
Table 7. Association of 6 SNPs from original GWA study [9] with ASD subtypes.
CHR SNP BP A1
a MAF_A
b MAF_U
c A2
d CHISQ
e OR
f UNADJ P FDR_BH
g BONF
h Subtype (# cases)
5 rs1896731 25934777 C 0.415 0.362 T 7.61 1.25 0.0058 0.0266 0.0348 Moderate (363)
5 rs10038113 25938099 C 0.471 0.420 T 6.85 1.23 0.0088 0.0266 0.0531 "
5 rs7704909 25934678 C 0.315 0.351 T 3.57 0.85 0.0589 0.0740 0.3533 "
5 rs4327572 26008578 T 0.314 0.349 C 3.38 0.85 0.0660 0.0740 0.3957 "
5 rs12518194 25987318 G 0.314 0.348 A 3.23 0.86 0.0725 0.0740 0.4350 "
5 rs4307059 26003460 C 0.312 0.345 T 3.19 0.86 0.0740 0.0740 0.4441 "
5 rs4307059 26003460 C 0.332 0.345 T 1.74 0.94 0.1870 0.3607 1.0000 Combined cases (1867)
5 rs12518194 25987318 G 0.334 0.348 A 1.68 0.94 0.1954 0.3607 1.0000 "
5 rs4327572 26008578 T 0.336 0.349 C 1.53 0.94 0.2155 0.3607 1.0000 "
5 rs7704909 25934678 C 0.339 0.351 T 1.38 0.95 0.2405 0.3607 1.0000 "
5 rs10038113 25938099 C 0.425 0.420 T 0.28 1.02 0.5978 0.7173 1.0000 "
5 rs1896731 25934777 C 0.365 0.362 T 0.10 1.02 0.7476 0.7476 1.0000 "
5 rs1896731 25934777 C 0.340 0.362 T 2.00 0.91 0.1576 0.4388 0.9456 Language-impaired (639)
5 rs10038113 25938099 C 0.402 0.420 T 1.28 0.93 0.2579 0.4388 1.0000 "
5 rs4307059 26003460 C 0.332 0.345 T 0.83 0.94 0.3629 0.4388 1.0000 "
5 rs4327572 26008578 T 0.336 0.349 C 0.77 0.94 0.3800 0.4388 1.0000 "
5 rs12518194 25987318 G 0.335 0.348 A 0.71 0.95 0.3991 0.4388 1.0000 "
5 rs7704909 25934678 C 0.340 0.351 T 0.60 0.95 0.4388 0.4388 1.0000 "
5 rs7704909 25934678 C 0.358 0.351 T 0.15 1.03 0.6983 0.9830 1.0000 Intermediate (478)
5 rs4327572 26008578 T 0.351 0.349 C 0.02 1.01 0.8895 0.9830 1.0000 "
5 rs12518194 25987318 G 0.346 0.348 A 0.01 0.99 0.9403 0.9830 1.0000 "
5 rs10038113 25938099 C 0.418 0.420 T 0.00 1.00 0.9469 0.9830 1.0000 "
5 rs1896731 25934777 C 0.361 0.362 T 0.00 1.00 0.9634 0.9830 1.0000 "
5 rs4307059 26003460 C 0.345 0.345 T 0.00 1.00 0.9830 0.9830 1.0000 "
5 rs7704909 25934678 C 0.337 0.351 T 0.57 0.94 0.4485 0.7486 1.0000 Mild (387)
5 rs4307059 26003460 C 0.334 0.345 T 0.37 0.95 0.5455 0.7486 1.0000 "
5 rs4327572 26008578 T 0.339 0.349 C 0.31 0.96 0.5759 0.7486 1.0000 "
5 rs12518194 25987318 G 0.337 0.348 A 0.31 0.96 0.5763 0.7486 1.0000 "
5 rs10038113 25938099 C 0.429 0.420 T 0.24 1.04 0.6239 0.7486 1.0000 "
5 rs1896731 25934777 C 0.364 0.362 T 0.02 1.01 0.8853 0.8853 1.0000 "
aMinor allele;
bMinor allele frequency-autistic cases;
cMAF-unaffected controls;
dMajor allele;
eChiSquare value;
fOdds ratio with respect to major allele;
gp-value adjusted using Benjamini-Hochberg False Discovery Rate method;
hBonferroni-adjusted p-value*CNV located in Chromosomal band as reported by Pinto et al. [15].
doi:10.1371/journal.pone.0019067.t007
Novel SNPs Associated with Autism Subtypes
PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e19067Biological relevance of SNP-containing genes
To examine the biological processes and pathways that might
be impacted by the SNP-associated genes, we performed pathway
analyses on the genes using Pathway Studio 7 software. Fig. 3
shows that 7 of the 9 SNP-containing genes are included in a gene
network with many genes leading to ‘‘axonogenesis,’’ a function
which has been reported to be enriched among genes overlapping
copy number variants in autistic patients [25]. HTR4 and GCH1
are network ‘‘hubs’’ connecting with many other genes, cellular
processes and disorders (see Figs. S3 and S4 for specific
connections). As illustrated in Fig. S3, HTR4 [5-hydroxytrypta-
mine (serotonin) receptor 4] regulates neurogenesis, long-term
synaptic potentiation and, in turn, learning and memory, as well as
the release of neurotransmitters (dopamine, acetylcholine), peptide
hormones (AVP, OXT, PRL, VIP) and steroid compounds
(cortisol, corticosterone). Thus, any alteration in the expression
or function of this gene can be expected to have wide-ranging
consequences on processes known to be affected by ASDs. It is
notable that one of the SNPs associated with HTR4, rs7725785, is
associated with three ASD subtypes (Table 6). However, the odds
ratio is 1.44 for the severe language-impaired subtype while it is
0.68 and 0.74 for the moderate and mild subtypes, respectively.
Interestingly, a reduction in HTR4 expression was observed only
for the language-impaired subtype of ASDs and not for the
moderate (savant) or mild subtypes in our earlier gene expression
study [14], suggesting that this SNP, which is located at an intron
boundary within HTR4, may play a role in level of expression.
Genetic variants in HTR4 have also been associated with
schizophrenia [26], bipolar disorder [27] and attention deficit/
hyperactivity disorder [28], further suggesting some functional
overlap among these neurological disorders. More recently, a de
novo translocation on chromosome 5 close to HTR4 has been
identified in an autistic boy [29], lending additional support for the
relevance of this gene in ASDs.
The other hub gene, GCH1 [GTP cyclohydrolase I], is the rate-
limiting enzyme in the de novo biosynthesis of tetrahydrobiopterin
which is, in turn, required for the biosynthesis of folate, serotonin,
dopamine, and catecholamines (Fig. S4), all of which are
important for neural development and functions. It is interesting
to note that elevated expression of GCH1 has been implicated in
mood disorders [30], while genetic polymorphisms or mutations in
GCH1 have been associated with pain sensitivity [31–33], and
dystonia [34], which are often associated with ASDs. Although
these genes are not likely to be causal for ASDs, genetic
polymorphisms in them may be associated with some of the
comorbid symptoms or pathobiology of ASDs.
Figure 3. Gene interaction network of genes associated with the intronic SNPs identified in Table 6. Genes from Table 6 are shown with
blue highlights while other genes in the network are shown in pink and small molecules are green. Processes are shown in yellow and disorders are
shown in purple. The orange entities represent functional complexes.
doi:10.1371/journal.pone.0019067.g003
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biological relevance of these QTL to ASDs and identify additional
candidate genes, such as HTR4 and GCH1, for functional testing.
Importantly, this study also reveals genetic biomarkers which not
only may be used for diagnostic screening of ASDs, but also offer
the additional advantage of being associated with ASD subtypes
that may be linked to specific and targeted therapies through
pharmacogenomics studies. Finally, the association of different
SNPs with the 4 subtypes of ASDs described here reinforces the
idea that there are multiple genetic etiologies giving rise to the
autistic spectrum, while the shared SNPs between different
subtypes may reveal common genetic mechanisms responsible
for core symptoms.
Summary
This study is the first to demonstrate the value of using a
combination of quantitative trait analysis and subphenotyping of
individuals with ASDs to identify genetic variants (SNPs) that
associate with specific behavioral phenotypes of ASDs. It is noted
that no Bonferroni-significant SNPs are detected when all 1867
autistic cases are combined into a single group and compared
against 2438 non-autistic controls. Thus, even though the number
of cases is lower in each of the subgroups, there is more power to
detect statistically significant SNPs associated with the more
homogeneous subgroups of individuals with ASDs than with the
combined group of cases. Subtyping also creates independent case
cohorts which are shown to replicate 10 of the novel SNPs
identified in this study, thus providing a form of internal
validation. Differences in minor allele frequencies of these 10
SNPs in the different cohorts further demonstrate the genetic
heterogeneity among the subtypes. Together, these findings not
only reveal novel subtype-dependent candidate genes for ASDs,
but also identify potential genetic markers for diagnostic screening.
Methods
GWA data used for this study
Genome-wide association data from the study by Wang et al.
[9] were downloaded from the Autism Speaks website at ftp://ftp.
autismspeaks.org/Data/CHOP_PLINK/AGRERELEASE.ped.
For this study, we used the file named CHOP.clean100121 where
the data were ‘‘cleaned’’ by Jennifer K. Lowe in the laboratory of
Daniel H. Geschwind, M.D., Ph.D. at UCLA. The cleaning
procedure involved extensive sample and pedigree validation,
exclusion of SNPs a) missing .10% data, b) with HWE p,0.001,
c) with MAF,0.01, and d) with .10 Mendelian errors. The final
dataset included 4327 genotyped individuals and 513,312 SNPs on
the Illumina HumanHap550 Bead Chip.
ADI-R data
ADI-R assessments for 2939 individuals were obtained from
Autism Speaks through Dr. Vlad Kustanovich of the Autism
Genetics Resource Exchange. Of these, 1867 individuals were
among the cases genotyped by Wang et al. [9]. Scores of 123 items
on the ADI-R score sheets of each individual were analyzed as
described by Hu and Steinberg [13] to identify ASD subtypes (that
is, phenotypic subgroups) which are represented in Fig. S2.
Determination of quantitative traits
Raw item scores from the Autism Diagnostic Interview-Revised
(ADI-R) score sheets of 2939 ASD cases were summed for spoken
language skills, non-verbal communication, play skills, social
development, and insistence on sameness/ritualistic behaviors.
The specific items used to obtain the total score per category for
each individual, shown in Table S1, were noted in an earlier study
[13]toexhibitaveragedifferences inseverityamongseveralsubtypes
ofASDs,describedbelow.Thesumsofitemscoreswithineachofthe
5 categories were used as quantitative traits for genetic association
analysesusing thegenotypedata reportedbyWang et al.[9].Profiles
of the traits across the 2939 individuals are shown in Fig. S1.
Subtyping of individuals with ASDs
Two thousand nine hundred and thirty nine (2939) individuals
with ASDs were divided into phenotypic subgroups using
clustering tools within the MeV software package [35], as
previously described by Hu and Steinberg [13]. Briefly, subtyping
of individuals with ASDs involved K-means cluster analysis (with
K=4) of scores from 123 items from the ADI-R score sheets of
each individual which were adjusted as described to fall into a
severity range of 0 (normal) to 3 (highest severity). A figure of merit
analysis (not shown) indicated that the individuals with ASDs were
optimally represented by 4 subgroups. A principal components
analysis (PCA) was then used to verify that the 4 subgroups of
individuals identified by the K-means cluster analyses were
distinguishable by this unsupervised test. Fig. S2 shows the
symptomatic profiles of the 4 ASD subtypes as well as their
separation into discernible clusters by PCA. The subtypes are
named ‘‘Language-impaired,’’ ‘‘Intermediate,’’ ‘‘Moderate,’’ and
‘‘Mild,’’ and contain 639, 478, 363, and 387 cases, respectively.
Quantitative trait association analyses
Using the score totals for the 5 categories of autistic symptoms
exhibited by each of 1867 cases as quantitative traits, we utilized
PLINK [36], a program to analyze whole genome association
data, to perform quantitative trait association analyses with the
genotype data reported by Wang et al. [9]. From the results of
each of the 5 analyses (Table S2) in this discovery phase, we
selected SNPs with unadjusted p-values,10
25, which prioritized
SNPs filtered by association with quantitative traits relevant to
ASDs. These filtered sets of SNPs were then used in case-control
association analyses, as described below.
Case-control association tests
Using the 5 sets of QTL generated for each symptom category,
association analyses using PLINK were performed with each set
wherethecases,inadditiontobeingtreated asasinglegroupof1867
cases vs. 2438 controls, were also divided into the 4 ASD subtypes
that were determined by the ADI-R cluster analyses described
above. It should be noted that each ASD subgroup represents an
entirely separate cohort of cases. From each of the 5 sets of genetic
association analyses with subtypes and QTL (Tables 1, 2, 3, 4, 5),
we selected SNPs associated with each ASD subtype with a
Bonferroni-adjusted p-value#0.05 and combined them (a total of
18 unique SNPs) for a second case-control association analysis using
the combined and subtyped ASD cases against controls. The results
of this final analysis are shown in Table 6.
Pathway analysis
Pathway Studio 7 software (Ariadne Genomics, Inc.) was used
to generate relational gene networks using the SNP-containing
genes listed in Table 6.
Supporting Information
Figure S1 Quantitative trait profiles generated by
summing the severity scores for ADI-R items for each
trait listed in Table S1.
(TIF)
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PLoS ONE | www.plosone.org 12 April 2011 | Volume 6 | Issue 4 | e19067Figure S2 Identification of ASD subtypes by cluster
analyses. A) Symptomatic profiles of the 4 ASD subtypes that
resulted from K-means cluster analyses of 123 ADI-R severity
scores per individual. In this figure, each row represents an
individual and each column represents an item on the ADI-R.
Black represents a score of 0 which is considered ‘‘normal,’’ while
the intensity of red indicates severity scores ranging from 1–3.
Gray represents unavailable data. The wide band of intensely red
items in the language-impaired subgroup corresponds to spoken
language. The 12 columns at the extreme right in each block
represent items corresponding to ‘‘Savant skills,’’ which appear to
be present at a slightly higher frequency in the group labeled
‘‘Moderate.’’ This group had been labeled ‘‘Savant’’ in our
previous study [13]. Note that each cluster contains an
independent cohort of cases. B) Principal components analysis
(PCA) of the individuals based on the 123 ADI-R severity scores.
Each subgroup of individuals identified in (A) is assigned a color,
which identifies individuals from that subgroup in the PCA. Red:
Language-impaired; Green: Intermediate; Yellow: Moderate;
Blue: Mild. Each point on the PCA represents an individual with
an ASD whose position is defined by his/her scores for the 123
ADI-R items.
(TIF)
Figure S3 Network connections centered on HTR4 from
Figure 3.
(TIF)
Figure S4 Network connections centered on GCH1 from
Figure 3.
(TIF)
Table S1 List of behavioral categories and associated
ADI-R items used for quantitative trait (QT) analyses.
(DOC)
Table S2 Quantitative trait loci associated with 5 ASD
traits. Language-impairment, deficits in nonverbal communica-
tion, impaired play skills, insistence on sameness and rituals, and
delayed social development.
(XLS)
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